HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Ryckewaert Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

3/2015Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Ryckewaert Research Topics

Disease

8Neoplasms (Cancer)
05/2023 - 07/2015
8Sarcoma (Soft Tissue Sarcoma)
01/2023 - 01/2015
4Neoplasm Metastasis (Metastasis)
01/2022 - 03/2017
3Hemangiosarcoma (Angiosarcoma)
05/2023 - 10/2018
3Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 06/2019
3Leiomyosarcoma
10/2020 - 01/2018
2Fibroma (Fibromatosis)
01/2020 - 11/2019
2Aggressive Fibromatosis (Desmoid)
01/2020 - 11/2019
1Uveal melanoma
01/2023
1Phyllodes Tumor (Cystosarcoma Phylloides)
05/2020
1Osteosarcoma (Osteogenic Sarcoma)
01/2020
1Endometrial Stromal Sarcoma
11/2019
1Adenosarcoma
11/2019
1Myxoma (Myxomas)
11/2019
1Brain Neoplasms (Brain Tumor)
06/2019
1Liposarcoma
01/2018
1Synovial Sarcoma (Synovioma)
01/2018
1Brain Diseases (Brain Disorder)
03/2017
1Prostatic Neoplasms (Prostate Cancer)
09/2015
1Chordoma
07/2015
1Neutropenia
03/2015

Drug/Important Bio-Agent (IBA)

2Immune Checkpoint InhibitorsIBA
01/2023 - 01/2022
2NivolumabIBA
10/2022 - 01/2022
2IfosfamideFDA LinkGeneric
10/2020 - 03/2017
2regorafenibIBA
01/2020 - 01/2018
2TrabectedinIBA
03/2015 - 01/2015
1Macrophage Colony-Stimulating FactorIBA
01/2023
1pembrolizumabIBA
01/2023
1cabozantinibIBA
10/2022
1IpilimumabIBA
01/2022
1Dihydrotachysterol (AT 10)IBA
01/2022
1Alkylating AgentsIBA
05/2020
1pazopanibFDA Link
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2020
1Estrogen ReceptorsIBA
11/2019
1Aromatase InhibitorsIBA
11/2019
1Progestins (Progestagens)IBA
11/2019
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2019
1Estrogens (Estrogen)FDA Link
11/2019
1Paclitaxel (Taxol)FDA LinkGeneric
10/2018
1Bevacizumab (Avastin)FDA Link
10/2018
1Vascular Endothelial Growth Factor CIBA
10/2018
1Programmed Cell Death 1 ReceptorIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Docetaxel (Taxotere)FDA Link
09/2015
1Imatinib Mesylate (Gleevec)FDA Link
07/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2015
1Alanine Transaminase (SGPT)IBA
03/2015
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2015

Therapy/Procedure

6Drug Therapy (Chemotherapy)
05/2023 - 03/2015
6Therapeutics
01/2022 - 01/2015
2Immunotherapy
01/2023 - 01/2018
1Adjuvant Chemotherapy
01/2022
1Palliative Care (Palliative Therapy)
09/2015
1Molecular Targeted Therapy
07/2015